Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
A topical over-the-counter combination product containing **lidocaine hydrochloride anhydrous**, **benzalkonium chloride**, and **glycerin**. Lidocaine is a small-molecule local anesthetic that blocks voltage-gated sodium channels in peripheral sensory neurons to produce temporary topical analgesia and relief of pain and itching, while benzalkonium chloride is a quaternary ammonium antiseptic that disrupts microbial membranes and helps reduce risk of infection in minor wounds; glycerin functions primarily as a humectant and skin-conditioning excipient within the formulation. This combination is used for first-aid management of minor cuts, scrapes, burns, and related superficial skin irritation, and is marketed in topical formats such as spray, gel, and cream, with Bactine being the best-known U.S. brand associated with the lidocaine and benzalkonium combination.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on glycerin + lidocaine hydrochloride anhydrous + benzalkonium chloride.